Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Stomach Neoplasms 3Neoplasm Metastasis 2Small Cell Lung Carcinoma 1Sarcoma 1Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Advanced Primary Liver Cancer 1

Interventions

Oxaliplatin 53Cisplatin 52Fluorouracil 50Capecitabine 48pembrolizumab 39Leucovorin 31Docetaxel 26Trastuzumab 23Paclitaxel 20Irinotecan 20Ramucirumab 13Bevacizumab 12Cetuximab 9Radiotherapy 8Surgical Procedures, Operative 7S 1 (combination) 7Nivolumab 7Epirubicin 7Carboplatin 6olaparib 5Platinum 5Everolimus 5Sunitinib 4Mitomycin 4trastuzumab deruxtecan 3lenvatinib 3epacadostat 3bemarituzumab 3apatinib 3Saline Solution 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Stomach Neoplasms × apatinib × Clear all
NCT03472365 2024-01-11

A Study of SHR-1210 in Combination With Capecitabine + Oxaliplatin or Apatinib in Treatment of Advanced Gastric Cancer

Jiangsu HengRui Medicine Co., Ltd.

Phase 2 Completed
67 enrolled 12 charts
Gastrointestinal

Stomach Neoplasms

NCT03042611 2022-07-08

ANGEL

Elevar Therapeutics

Phase 3 Completed
460 enrolled 16 charts
Gastrointestinal

Neoplasm Metastasis, Neoplasms, Stomach Neoplasms

NCT01512745 2016-10-17

Phase III Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer

Jiangsu HengRui Medicine Co., Ltd.

Phase 3 Completed
267 enrolled 11 charts
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡